Provision of investigational drug after clinical research: review of literature, national and international guidelines.
暂无分享,去创建一个
[1] G. Lyman,et al. Availability of experimental therapy outside oncology randomized clinical trials in the United States. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Doris Schroeder. Obrigações pós-pesquisa , 2008 .
[3] B. S. Junior. Acesso às drogas na pesquisa clínica , 2009 .
[4] P. Lacativa,et al. [Profile of clinical research subjects in an independent outpatient center]. , 2008, Ciencia & saude coletiva.
[5] C. Grady,et al. Post-trial access to tested interventions: the views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study. , 2006, AIDS research and human retroviruses.
[6] Edward Mills,et al. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials. , 2009, Developing world bioethics.
[7] Seema K. Shah,et al. Planning for posttrial access to antiretroviral treatment for research participants in developing countries. , 2009, American journal of public health.
[8] J. R. Goldim. O uso de drogas ainda experimentais em assistência: extensão de pesquisa, uso compassivo e acesso expandido , 2008 .
[9] A. D. L. A. D. Araújo,et al. Perfil da assistência farmacêutica na atenção primária do Sistema Único de Saúde , 2008 .
[10] Z. Zong. Should post-trial provision of beneficial experimental interventions be mandatory in developing countries? , 2008, Journal of Medical Ethics.
[11] G. Kaebnick. How to think about stemming an insurgency. , 2004, The Hastings Center report.
[12] S. Maman,et al. Access to treatment in HIV prevention trials: perspectives from a South African community. , 2009, Developing world bioethics.
[13] Sonia Mansoldo Dainesi. Fornecimento de medicamentos pós-pesquisa , 2011 .
[14] Cary P Gross,et al. Access to experimental drugs for terminally ill patients. , 2008, JAMA.
[15] C. Grady. Ethics of international research: what does responsiveness mean? , 2006, The virtual mentor : VM.
[16] C. Grady,et al. Moral standards for research in developing countries: from "reasonable availability" to "fair benefits". , 2004, The Hastings Center report.
[17] R. Walensky,et al. Access to Medications and Medical Care After Participation in HIV Clinical Trials: A Systematic Review of Trial Protocols and Informed Consent Documents , 2009 .
[18] W. Tierney,et al. Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in western Kenya , 2005, Journal of Medical Ethics.
[19] Sonia Mansoldo Dainesi. Como fazer valer a máxima da ética médica Primum non nocer ao oferecer continuidade de tratamento com drogas experimentais a pacientes de pesquisa clínica , 2009 .
[20] Haiana Charifker Schindler,et al. Regulamentações, conflitos e ética da pesquisa médica em países em desenvolvimento , 2006 .
[21] R. Walensky,et al. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. , 2009, HIV clinical trials.
[22] Janice M. Ballou,et al. Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study , 2009, Journal of Medical Ethics.